Sterling Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Sterling Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-95,970	Closed	-$1.48M	–	65
2018 Q4	$1.48M	Sell	95,970 -12,828	-12%	-$263K	1.24%	23
2018 Q3	$2.34M	Sell	108,798 -758	-0.7%	-$17.6K	1.7%	17
2018 Q2	$2.66M	Buy	109,556 +32,954	+43%	+$672K	2.07%	15
2018 Q1	$1.31M	Buy	76,602 +18,943	+33%	+$370K	1.06%	27
2017 Q4	$1.09M	Buy	57,659 +902	+2%	+$13.6K	1.17%	29
2017 Q3	$999K	Sell	56,757 -2,521	-4%	-$56.7K	1.36%	27
2017 Q2	$1.97M	Buy	+59,278	New	+$1.83M	2.6%	13

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sterling Investment Management's TEVA Position: Q1 2019 in Review

Sterling Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2019, closing a stake of 95,970 shares — an estimated $1.48M sold.

Sterling Investment Management first reported a position in TEVA in Q2 2017 and held it in 7 quarters. The position peaked at $2.66M in Q2 2018. 521 funds tracked by Wall St. Rank hold TEVA as of Q1 2019.

Sterling Investment Management reported no remaining Teva Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
Sterling Investment Management sold 95,970 Teva Pharmaceuticals shares in Q1 2019, an estimated $1.48M.
Sterling Investment Management first reported a position in Teva Pharmaceuticals in Q2 2017 and held it in 7 quarters.
Sterling Investment Management's Teva Pharmaceuticals position peaked at $2.66M in Q2 2018.
521 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2019.

Based on Sterling Investment Management's 13F filing for Q1 2019, filed 24 Apr 2019.